Oaktree Acquisition Corp. III Life Sciences (OACC) Payables (2024 - 2026)

Oaktree Acquisition Corp. III Life Sciences filings provide 3 years of Payables readings, the most recent being $763287.0 for Q1 2026.

  • Quarterly Payables rose 87.31% to $763287.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $763287.0 through Mar 2026, up 87.31% year-over-year, with the annual reading at $513792.0 for FY2025, 6.13% down from the prior year.
  • Payables hit $763287.0 in Q1 2026 for Oaktree Acquisition Corp. III Life Sciences, up from $513792.0 in the prior quarter.
  • Across five years, Payables topped out at $763287.0 in Q1 2026 and bottomed at $393378.0 in Q2 2025.
  • Average Payables over 3 years is $508539.5, with a median of $469861.5 recorded in 2025.
  • The largest annual shift saw Payables dropped 6.13% in 2025 before it skyrocketed 87.31% in 2026.
  • Oaktree Acquisition Corp. III Life Sciences' Payables stood at $547339.0 in 2024, then fell by 6.13% to $513792.0 in 2025, then surged by 48.56% to $763287.0 in 2026.
  • Per Business Quant, the three most recent readings for OACC's Payables are $763287.0 (Q1 2026), $513792.0 (Q4 2025), and $425931.0 (Q3 2025).